Company: IPSC
Filing Date: 2025-11-21
Form Type: PRE 14A
Source: 0001104659-25-114992
Chunk: 6

Company: Century Therapeutics, Inc.
Filing Date: 2025-11-21
Form: PRE 14A
Chunk 6
---
 means or in person. Directors and employees will not be paid any additional compensation for soliciting proxies. We may reimburse brokerage firms, banks and other agents for the cost of forwarding proxy materials to beneficial owners.

Notice of Special Meeting of Stockholders and 2025 Proxy Statement | 2

| ​ | SECURITY OWNERSHIP OF CERTAIN BENEFICIALOWNERS AND MANAGEMENT | ​ |

The following table sets forth certain information regarding the beneficial ownership of Common Stock as of November 15, 2025, except to the extent otherwise indicated in the footnotes below, by (a) each person known by us to be the beneficial owner of more than 5% of the outstanding shares of Common Stock, (b) each named executive officer of the Company, (c) each director of the Company, and (d) all executive officers and directors as a group. The percentage of Common Stock outstanding is based on 87,313,356 shares of our Common Stock outstanding as of November 15, 2025. For purposes of the table below, and in accordance with the rules of the SEC, we deem shares of Common Stock subject to options that are currently exercisable or exercisable within sixty days of November 15, 2025 to be outstanding and to be beneficially owned by the person holding the options or warrants for the purpose of computing the percentage ownership of that person, but we do not treat them as outstanding for the purpose of computing the percentage ownership of any other person. Except as otherwise noted, each of the persons or entities in this table has sole voting and investing power with respect to all of the shares of Common Stock beneficially owned by them, subject to community property laws, where applicable. Except as otherwise noted below, the street address of each beneficial owner is c/o Century Therapeutics, Inc., 25 North 38th Street, 11th Floor, Philadelphia, PA 19104.

| ​ | ​                | NAME OF BENEFICIAL OWNER                                        | ​ | ​          | SHARES BENEFICIALLY OWNED |   |   |        | ​ | ​ |
| ​ | NUMBER OF SHARES | ​                                                               | ​ | PERCENTAGE |                         ​ | ​ |   |        |   |   |
| ​ | ​                | Greater than 5% Stockholders                                    | ​ | ​          |                         ​ | ​ | ​ | ​      | ​ | ​ |
| ​ | ​                | Versant Entities(1)                                             | ​ | ​          |                12,166